#METABOLOMICS WORKBENCH neo_009_20170616_101623 DATATRACK_ID:978 STUDY_ID:ST000621 ANALYSIS_ID:AN000953 PROJECT_ID:PR000454
VERSION             	1
CREATED_ON             	June 19, 2017, 1:45 pm
#PROJECT
PR:PROJECT_TITLE                 	Untargeted metabolomic changes in Chlamydomonas reinhardtii treated with lipid
PR:PROJECT_TITLE                 	inducing small molecules
PR:PROJECT_SUMMARY               	A study to investigate the effect of small molecule lipid inducing compounds
PR:PROJECT_SUMMARY               	that leads to hyper accumulation of lipids in N replete cells of Chlamydomonas
PR:PROJECT_SUMMARY               	reinhardtii. These compounds were identified through a high throughput screening
PR:PROJECT_SUMMARY               	designed for that purpose. During that screening, we screened 43,783 compounds
PR:PROJECT_SUMMARY               	and identified 367 primary hits. These 367 hits were further retested using a
PR:PROJECT_SUMMARY               	8-point dilution series (from 0.25 to 30 uM) and verified the activity of 250
PR:PROJECT_SUMMARY               	compounds that induce the hyper lipid accumulating phenotype in algae. Once the
PR:PROJECT_SUMMARY               	hit compounds were identified and confirmed, we then performed extensive
PR:PROJECT_SUMMARY               	chemoinformatics analysis to look for common scaffolds and identified several
PR:PROJECT_SUMMARY               	common substructures. We then selected 15 top performing compounds from 5
PR:PROJECT_SUMMARY               	diverse structural groups and tested biochemical parameters such as growth,
PR:PROJECT_SUMMARY               	lipid accumulating capacity, effect on photosynthetic rates, respiration rates,
PR:PROJECT_SUMMARY               	oxygen consumption rates, analysis of different lipid species to quantify and
PR:PROJECT_SUMMARY               	identify fatty acid species using GC-MS. To understand the global changes in the
PR:PROJECT_SUMMARY               	metabolome, 2 structurally different compounds were selected and compared with
PR:PROJECT_SUMMARY               	cells grown without compounds as control for untargeted metabolomics analysis.
PR:INSTITUTE                     	University of Nebraska-Lincoln
PR:DEPARTMENT                    	Biochemistry
PR:LABORATORY                    	FATTTLab
PR:LAST_NAME                     	Wase
PR:FIRST_NAME                    	Nishikant
PR:ADDRESS                       	1901 Beadle Center, Vine Street, 1901 VINE STREET, Lincoln, NE, 68588-0664, USA
PR:EMAIL                         	nishikant.wase@gmail.com
PR:PHONE                         	4023109931
PR:FUNDING_SOURCE                	NCESR-704, Nebraska Center for Energy Science Research; EPS-1004094 and 1264409,
PR:FUNDING_SOURCE                	National Science Foundation ; NSF CBET : 1402896, National Science Foundation
PR:CONTRIBUTORS                  	Nishikant Wase, Jiri Adamec, Ron Cerny, Girish Rasineni, Paul N Black, Concetta
PR:CONTRIBUTORS                  	DiRusso
#STUDY
ST:STUDY_TITLE                   	Untargeted metabolomic changes in Chlamydomonas reinhardtii treated with lipid
ST:STUDY_TITLE                   	inducing small molecules
ST:STUDY_SUMMARY                 	A study to investigate the effect of small molecule lipid inducing compounds
ST:STUDY_SUMMARY                 	that leads to hyper accumulation of lipids in N replete cells of Chlamydomonas
ST:STUDY_SUMMARY                 	reinhardtii. These compounds were identified through a high throughput screening
ST:STUDY_SUMMARY                 	designed for that purpose. During that screening, we screened 43,783 compounds
ST:STUDY_SUMMARY                 	and identified 367 primary hits. These 367 hits were further retested using a
ST:STUDY_SUMMARY                 	8-point dilution series (from 0.25 to 30 uM) and verified the activity of 250
ST:STUDY_SUMMARY                 	compounds that induce the hyper lipid accumulating phenotype in algae. Once the
ST:STUDY_SUMMARY                 	hit compounds were identified and confirmed, we then performed extensive
ST:STUDY_SUMMARY                 	chemoinformatics analysis to look for common scaffolds and identified several
ST:STUDY_SUMMARY                 	common substructures. We then selected 15 top performing compounds from 5
ST:STUDY_SUMMARY                 	diverse structural groups and tested biochemical parameters such as growth,
ST:STUDY_SUMMARY                 	lipid accumulating capacity, effect on photosynthetic rates, respiration rates,
ST:STUDY_SUMMARY                 	oxygen consumption rates, analysis of different lipid species to quantify and
ST:STUDY_SUMMARY                 	identify fatty acid species using GC-MS. To understand the global changes in the
ST:STUDY_SUMMARY                 	metabolome, 2 structurally different compounds were selected and compared with
ST:STUDY_SUMMARY                 	cells grown without compounds as control for untargeted metabolomics analysis.
ST:INSTITUTE                     	University of Nebraska-Lincoln
ST:DEPARTMENT                    	Department of Biochemistry
ST:LAST_NAME                     	Wase
ST:FIRST_NAME                    	Nishikant
ST:ADDRESS                       	Department of Biochemistry, 1901 VINE STREET
ST:EMAIL                         	nishikant.wase@gmail.com
ST:PHONE                         	4023109931
#SUBJECT
SU:SUBJECT_TYPE                  	Photosynthetic organism
SU:SUBJECT_SPECIES               	Chlamydomonas reinhardtii
SU:TAXONOMY_ID                   	3055
SU:GENOTYPE_STRAIN               	CC125 Wild type
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Additional sample data
SUBJECT_SAMPLE_FACTORS           	-	CD06241603	Group:Control	Treatment=DMSO
SUBJECT_SAMPLE_FACTORS           	-	CD06241601B	Group:Control	Treatment=DMSO
SUBJECT_SAMPLE_FACTORS           	-	CD06241602	Group:Control	Treatment=DMSO
SUBJECT_SAMPLE_FACTORS           	-	CD06241619	Group:cmp_784	Treatment=5 uM Compound WD10784
SUBJECT_SAMPLE_FACTORS           	-	CD06241620	Group:cmp_784	Treatment=5 uM Compound WD10784
SUBJECT_SAMPLE_FACTORS           	-	CD06241621	Group:cmp_784	Treatment=5 uM Compound WD10784
SUBJECT_SAMPLE_FACTORS           	-	CD06241608	Group:cmp_030	Treatment=5 uM Compound WD30030
SUBJECT_SAMPLE_FACTORS           	-	CD06241609	Group:cmp_030	Treatment=5 uM Compound WD30030
SUBJECT_SAMPLE_FACTORS           	-	CD06241607	Group:cmp_030	Treatment=5 uM Compound WD30030
#COLLECTION
CO:COLLECTION_SUMMARY            	Triplicate cultures were grown and treated as indicated and harvested at 72 h.
CO:COLLECTION_SUMMARY            	The harvested cells were freeze-dried and weighted 10 ± 0.5 mg dry powder. To
CO:COLLECTION_SUMMARY            	extract the metabolites, 500 uL of 75% MeOH in 0.15 M NaCl was added and
CO:COLLECTION_SUMMARY            	metabolites were extracted using bead beating 50 Hz for 5 min. The homogenate
CO:COLLECTION_SUMMARY            	was sonicated in water bath for 5 min and then 300 uL of 0.15 M NaCl was added
CO:COLLECTION_SUMMARY            	and then 1 mL of chloroform:methanol (1:2) with 0.01% BHT was added. Samples
CO:COLLECTION_SUMMARY            	were homogenized and allowed to phase separate on ice for 30 mins. Finally tubes
CO:COLLECTION_SUMMARY            	were centrifuged for 10 min to separate the polar and non-polar layer. Top polar
CO:COLLECTION_SUMMARY            	layer was removed and an aliquot of 200 uL was used for analysis. Samples were
CO:COLLECTION_SUMMARY            	evaporated to dryness in SpeedVac and metabolites were reconstituted in 0.03%
CO:COLLECTION_SUMMARY            	formic acid in analytical-grade water. Debris was removed via centrifugation and
CO:COLLECTION_SUMMARY            	the supernatant was subjected to UPLC-MS analysis.
CO:SAMPLE_TYPE                   	Photosynthetic organism
CO:COLLECTION_METHOD             	Centrifugation from suspension culture.
CO:COLLECTION_LOCATION           	FATTTLab Department of Biochemistry, Univ of Nebraska-Lincoln
CO:STORAGE_CONDITIONS            	After harvest, cells were kept at -80 C until extraction.
CO:COLLECTION_VIALS              	2 mL Eppendorf tubes
#TREATMENT
TR:TREATMENT_SUMMARY             	For compound treatment, cells from mid-log phase culture were harvested, washed
TR:TREATMENT_SUMMARY             	once with fresh sterile TAP media and inoculated at starting density of 5 x 105
TR:TREATMENT_SUMMARY             	cells/mL. Thus for the current experiment 3 different treatment conditions were
TR:TREATMENT_SUMMARY             	generated. Cells without compound treatment were negative control for the lipid
TR:TREATMENT_SUMMARY             	accumulation and 2 compounds were used to generate treatment conditions. All
TR:TREATMENT_SUMMARY             	compounds were used at a final concentration of 5 M (this concentration was
TR:TREATMENT_SUMMARY             	determined using a dose-response curve). For all cultures, 250 mL Erlenmeyer
TR:TREATMENT_SUMMARY             	flasks with rubber stopper adopted to facilitate gas exchange were used and
TR:TREATMENT_SUMMARY             	maintained in horizontal orbital shaking growing chamber (Innova 43; New
TR:TREATMENT_SUMMARY             	Brunswick). At the end of 72h, cells were harvested, media was removed via
TR:TREATMENT_SUMMARY             	centrifugation and biomass was stored at -80 C until metabolite extraction.
TR:CELL_MEDIA                    	Tris-Acetate Phoshphate (TAP) media.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Triplicate cultures were grown and treated as indicated and harvested at 72 h.
SP:SAMPLEPREP_SUMMARY            	The harvested cells were freeze-dried and weighted 10 ± 0.5 mg dry powder. To
SP:SAMPLEPREP_SUMMARY            	extract the metabolites, 500 uL of 75% MeOH in 0.15 M NaCl was added and
SP:SAMPLEPREP_SUMMARY            	metabolites were extracted using bead beating 50 Hz for 5 min. The homogenate
SP:SAMPLEPREP_SUMMARY            	was sonicated in water bath for 5 min and then 300 uL of 0.15 M NaCl was added
SP:SAMPLEPREP_SUMMARY            	and then 1 mL of chloroform:methanol (1:2) with 0.01% BHT was added. Samples
SP:SAMPLEPREP_SUMMARY            	were homogenized and allowed to phase separate on ice for 30 mins. Finally tubes
SP:SAMPLEPREP_SUMMARY            	were centrifuged for 10 min to separate the polar and non-polar layer. Top polar
SP:SAMPLEPREP_SUMMARY            	layer was removed and an aliquot of 200 uL was used for analysis. Samples were
SP:SAMPLEPREP_SUMMARY            	evaporated to dryness in SpeedVac and metabolites were reconstituted in 0.03%
SP:SAMPLEPREP_SUMMARY            	formic acid in analytical-grade water. Debris was removed via centrifugation and
SP:SAMPLEPREP_SUMMARY            	the supernatant was subjected to UPLC-MS analysis
SP:EXTRACTION_METHOD             	Bead beating
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Agilent 1200
CH:COLUMN_NAME                   	ACE 5 C18-300 (100 x 2.1mm)
CH:FLOW_RATE                     	0.1 mL/min
CH:SOLVENT_A                     	0.1% formic acid in water
CH:SOLVENT_B                     	0.1% formic acid in MetOH
CH:SAMPLE_INJECTION              	8 uL
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:MS_COMMENTS                   	-
MS:INSTRUMENT_NAME               	Waters Synapt G2 S QTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_RESULTS_FILE               	ST000621_AN000953_Results.txt	UNITS:intensity
#END